| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 3.40e-04 | 645 | 30 | 6 | GO:0140640 | |
| GeneOntologyMolecularFunction | ubiquitin-modified protein reader activity | 4.08e-04 | 20 | 30 | 2 | GO:0140036 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.07e-04 | 262 | 30 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein reader activity | 6.41e-04 | 25 | 30 | 2 | GO:0140035 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 9.00e-04 | 127 | 30 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.41e-03 | 37 | 30 | 2 | GO:0140658 | |
| GeneOntologyCellularComponent | ISWI-type complex | 1.79e-04 | 14 | 30 | 2 | GO:0031010 | |
| Domain | Bromodomain_CS | 8.45e-04 | 26 | 31 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 1.71e-03 | 37 | 31 | 2 | PS00633 | |
| Domain | Bromodomain | 1.81e-03 | 38 | 31 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.10e-03 | 41 | 31 | 2 | PS50014 | |
| Domain | BROMO | 2.20e-03 | 42 | 31 | 2 | SM00297 | |
| Domain | Bromodomain | 2.20e-03 | 42 | 31 | 2 | IPR001487 | |
| Domain | - | 2.20e-03 | 42 | 31 | 2 | 1.20.920.10 | |
| Domain | EGF | 6.82e-03 | 235 | 31 | 3 | SM00181 | |
| Domain | EGF-like_dom | 7.99e-03 | 249 | 31 | 3 | IPR000742 | |
| Pubmed | CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L. | 2.31e-06 | 3 | 31 | 2 | 15640247 | |
| Pubmed | 4.60e-05 | 1116 | 31 | 7 | 31753913 | ||
| Pubmed | Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | 1.60e-04 | 21 | 31 | 2 | 22959728 | |
| Pubmed | 2.28e-04 | 25 | 31 | 2 | 25085501 | ||
| Pubmed | 3.99e-04 | 33 | 31 | 2 | 24727668 | ||
| Interaction | ZNF784 interactions | 1.17e-05 | 31 | 29 | 3 | int:ZNF784 | |
| Cytoband | 5q35 | 1.11e-04 | 23 | 31 | 2 | 5q35 | |
| Cytoband | 8q24.3 | 2.67e-03 | 113 | 31 | 2 | 8q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 4.82e-03 | 153 | 31 | 2 | chr2q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 4.94e-03 | 155 | 31 | 2 | chr1p32 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-06 | 180 | 31 | 4 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-06 | 192 | 31 | 4 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-06 | 192 | 31 | 4 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.02e-05 | 197 | 31 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-05 | 198 | 31 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 198 | 31 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 200 | 31 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 1.84e-04 | 22 | 27 | 2 | EFO_0009312 | |
| Disease | apolipoprotein B measurement | 3.02e-04 | 663 | 27 | 5 | EFO_0004615 | |
| Disease | total lipids in lipoprotein particles measurement | 8.86e-04 | 48 | 27 | 2 | EFO_0022309 | |
| Disease | triglycerides in LDL measurement | 1.20e-03 | 56 | 27 | 2 | EFO_0022320 | |
| Disease | triglycerides in small VLDL measurement | 1.43e-03 | 61 | 27 | 2 | EFO_0022145 | |
| Disease | triglycerides in medium LDL measurement | 1.47e-03 | 62 | 27 | 2 | EFO_0022322 | |
| Disease | phospholipids in large VLDL measurement | 1.47e-03 | 62 | 27 | 2 | EFO_0022169 | |
| Disease | triglycerides in small LDL measurement | 1.62e-03 | 65 | 27 | 2 | EFO_0022323 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.69e-03 | 260 | 27 | 3 | EFO_0008317 | |
| Disease | triglycerides in very small VLDL measurement | 1.77e-03 | 68 | 27 | 2 | EFO_0022144 | |
| Disease | stem Cell Growth Factor beta measurement | 2.15e-03 | 75 | 27 | 2 | EFO_0008292 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.33e-03 | 291 | 27 | 3 | EFO_0008317, EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RCRAAAFFLSLFLCL | 46 | Q9H0X4 | |
| FLARCLRPCFDQTVF | 196 | Q86XJ0 | |
| RRAFATCLRSPFCEE | 606 | Q8TAP6 | |
| RLSPFRFEDFCAALV | 261 | Q12830 | |
| RFSKPDSDRFVFLLC | 1351 | Q9P2D1 | |
| FCSLFRTAFRLPDFE | 26 | Q9BXF3 | |
| LPFCRSRLINHFFCE | 181 | Q8NG84 | |
| RFPCTLACEARHFLL | 901 | Q16787 | |
| RFDTAFFLCCLREPP | 211 | A8MXV4 | |
| RTLLLDCRPFLAFCR | 26 | Q05923 | |
| PTDCLSCDRFFFLLR | 1581 | Q92824 | |
| FSLELLCPFFCLELL | 236 | Q6ZWI9 | |
| HRCIFDRRFSCLPEL | 111 | O14559 | |
| CRCPLDRFQDFALID | 231 | Q8WZ55 | |
| SHCPDFFLFLCRLLS | 681 | Q6NUI2 | |
| LDCSRDFRPFLCALY | 71 | Q9NPG1 | |
| PFVCIFSNRELRRCF | 336 | P60893 | |
| LFREFCATRPELSRC | 66 | P43250 | |
| SLRCHEDLPLFLRCF | 646 | Q9Y2M0 | |
| FPLDLCTDSFFTSRR | 866 | Q9Y2M0 | |
| PRFLLLESQAFRCCL | 851 | B5MCY1 | |
| FPRLFVEAFTSRCCE | 36 | Q5SWL8 | |
| AAREIRRFSFCCSPE | 16 | Q13501 | |
| FLLRFRFCSIACQRP | 511 | Q9UNK9 | |
| LRDCEASLFCNPSFI | 2226 | Q63HN8 | |
| LIESRLFCRCSFDVP | 201 | Q8N2E2 | |
| FLCRALCLFPRVFAA | 11 | Q9NPL8 | |
| SIDEFCRKFRLDCPL | 91 | Q9UK41 | |
| RDAAEFELFFRRCPF | 36 | Q6XQN6 | |
| FCPHCSRIFTSDRLL | 286 | Q6S9Z5 | |
| FRDPRDLRCFICGDA | 1351 | Q5TAX3 | |
| FACRFCAKPFRRSSD | 196 | Q8NCA9 |